HIV integrase inhibitors (GlaxoSmithKline/Shionogi)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameHIV integrase inhibitors (GlaxoSmithKline/Shionogi)
Drug Alias NameGSK-867GSK-1362867
ClassificationSmall molecules
Mechanisms of ActionHIV integrase inhibitors
TargetsHIV integrase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline PlcShionogi & Co Ltd
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A